register

News & Trends - Pharmaceuticals

Boehringer Ingelheim’s dynamic evolution of ‘Life Forward’

Health Industry Hub | October 31, 2023 |

Pharma News: Boehringer Ingelheim has embarked on a transformative corporate rebrand, heralded by a vibrant new logo and a revitalised corporate colour palette. This shift encompasses not only a fresh visual identity but also the introduction of their inaugural brand slogan, Life Forward. The significance of this endeavour, as expressed by Boehringer’s Head of Corporate Affairs, extends far beyond a mere cosmetic alteration.

The company contemplates, “When future generations ask us to tell the story of how we tackled the most pressing challenges of our time, what will we say?”

This new direction takes root in the bedrock of the company’s overarching mission, encapsulated in the phrase ‘transforming lives for generations.’ It underscores how the corporation responds to the contemporary challenges of today and the unknown horizons of tomorrow, and the impact it aspires to create.

In a world grappling with non-communicable and infectious diseases, burgeoning aging populations, and healthcare systems pushed to their limits, the company takes on the task of addressing unmet medical needs. These critical areas encompass cardio-renal-metabolic (CRM) diseases, inflammation, oncology, and mental health.

Médard Schoenmaeckers, the Head of Corporate Affairs at Boehringer Ingelheim, firmly acknowledges the responsibility that comes with this role. “We have a responsibility to help address these challenges,” he stated. “Momentum to introduce our evolved brand has never been better with our well-stocked innovation pipeline that will make significant differences for both humans and animals.”

This evolution of the brand introduces a contemporary, digitally-driven brand experience. It takes inspiration from the company’s rich history as a family-owned enterprise, builds on their established record of pioneering collaborations, and amplifies their unwavering commitment to sustainability.

At the heart of this reimagined corporate brand lies a spirit of unwavering optimism. In everything we do and say, we look positively into the future because we know we can shape and influence it for the better and want to inspire others to join us,” added Mr Schoenmaeckers. “We have nearly 140 years of experience navigating the challenging dynamics of healthcare. And it is from that acquired resilience that we draw our confidence and the confidence that we can do better for the generations that come after us.”

Notably, other giants in the healthcare industry, such as Pfizer and the Johnson & Johnson Family of Companies, have also undertaken significant branding updates to remain in sync with the ever-evolving healthcare and consumer landscape.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Manoj Saxena - Bayer

Breaking the mold: Bayer GM on the future of pharma workplaces – Reimagining Healthcare Senior Leadership Series

Health Industry Hub | July 18, 2024 |

In the latest episode of the Reimagining Healthcare senior leadership series, Manoj Saxena, General Manager Pharmaceuticals ANZ at Bayer voiced […]

More


News & Trends - Pharmaceuticals

Matt Zeller, Country President of Novartis ANZ

Novartis Country President talks essentials in shaping the future of health policy: Reimagining Healthcare senior leadership series

Health Industry Hub | July 18, 2024 |

In this episode of the Reimagining Healthcare senior leadership series, Matt Zeller, Country President of Novartis ANZ, explores how health […]

More


Medical

First guidelines to stamp out rising scientific integrity issues in medical journals

First guidelines to stamp out rising scientific integrity issues in medical journals

Health Industry Hub | July 18, 2024 |

The number of retractions issued for scientific research articles in 2023 exceeded 10,000 – smashing annual records. To date, publishers […]

More


News & Trends - Pharmaceuticals

Gilead secures MSAC nod for CAR-T therapy

Gilead secures MSAC nod for CAR-T therapy

Health Industry Hub | July 18, 2024 |

Pharma News: Gilead Sciences welcomes the Medical Services Advisory Committee (MSAC) recommendation for public funding of Yescarta (axicabtagene ciloleucel) as […]

More


This content is copyright protected. Please subscribe to gain access.